Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue
- PMID: 1939640
- PMCID: PMC295652
- DOI: 10.1172/JCI115457
Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue
Abstract
It has been reported that the severe complication of dengue virus infection, dengue hemorrhagic fever (DHF) is much more commonly observed during secondary dengue virus infections than primary infections. In order to elucidate the role of T lymphocytes in the pathogenesis of DHF, we attempted to determine whether T lymphocytes are activated in vivo during dengue virus infections, by examining the levels of soluble IL-2 receptor (sIL-2R), soluble CD4 (sCD4), soluble CD8 (sCD8), interleukin-2 (IL-2) and interferon-gamma (IFN gamma) in the sera of 59 patients with DHF and 41 patients with dengue fever (DF). The levels of sIL-2R, sCD4, sCD8, IL-2, and IFN gamma were significantly higher in the acute sera of patients with DHF than in the sera of healthy children (P less than 0.001 for all markers). The acute sera of patients with DF contained higher levels of sIL-2R, sCD4, IL-2, and IFN gamma than the sera of healthy children (P less than 0.001 for sIL-2R, IL-2, and IFN gamma; P less than 0.05 for sCD4), but did not have elevated levels of sCD8. The levels of sIL-2R (P less than 0.05), sCD4 (P less than 0.001), and sCD8 (P less than 0.001) were higher in DHF than in DF on days 3-4 after the onset of fever. The levels of IL-2 and IFN gamma in patients with DHF were highest 1 d before defervescence. There were no significant differences in the levels of sIL-2R, sCD4, sCD8, IL-2, and IFN gamma among grades 1, 2, and 3 of DHF. These results indicate (a) T lymphocytes are activated and produce IL-2 and IFN gamma in vivo during DHF and DF, (b) CD4+ T lymphocytes are activated in DHF and DF, and the level of activation is higher in DHF than in DF, and (c) activation of CD8+ T lymphocytes is evident in DHF, but not in DF.
Similar articles
-
T cell activation in vivo by dengue virus infection.J Clin Lab Immunol. 1995;46(1):35-40. J Clin Lab Immunol. 1995. PMID: 9363590
-
Serum soluble CD4 and CD8 levels in polymyalgia rheumatica.J Rheumatol. 1994 Oct;21(10):1865-9. J Rheumatol. 1994. PMID: 7837152 Clinical Trial.
-
The effects of nonsteroidal antiinflammatory drug therapy in early rheumatoid arthritis on serum levels of soluble interleukin 2 receptor, CD4, and CD8.J Rheumatol. 1993 Nov;20(11):1857-62. J Rheumatol. 1993. PMID: 8308770 Clinical Trial.
-
Immunopathogenesis of dengue virus infection.J Biomed Sci. 2001 Sep;8(5):377-88. doi: 10.1007/BF02255946. J Biomed Sci. 2001. PMID: 11549879 Review.
-
[Immunological findings of bronchoalveolar lavage fluid (BALF) in sarcoidosis; analysis of soluble CD4 molecule and soluble CD8 molecule].Nihon Rinsho. 1994 Jun;52(6):1550-5. Nihon Rinsho. 1994. PMID: 8046840 Review. Japanese.
Cited by
-
Immuno-Haematologic Aspects of Dengue Infection: Biologic Insights and Clinical Implications.Viruses. 2024 Jul 6;16(7):1090. doi: 10.3390/v16071090. Viruses. 2024. PMID: 39066252 Free PMC article. Review.
-
An emerging role for the anti-inflammatory cytokine interleukin-10 in dengue virus infection.J Biomed Sci. 2013 Jun 25;20(1):40. doi: 10.1186/1423-0127-20-40. J Biomed Sci. 2013. PMID: 23800014 Free PMC article. Review.
-
Dengue virus selectively induces human mast cell chemokine production.J Virol. 2002 Aug;76(16):8408-19. doi: 10.1128/jvi.76.16.8408-8419.2002. J Virol. 2002. PMID: 12134044 Free PMC article.
-
A protective role for dengue virus-specific CD8+ T cells.J Immunol. 2009 Apr 15;182(8):4865-73. doi: 10.4049/jimmunol.0801974. J Immunol. 2009. PMID: 19342665 Free PMC article.
-
Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a.J Clin Invest. 1996 Oct 1;98(7):1684-91. doi: 10.1172/JCI118964. J Clin Invest. 1996. PMID: 8833919 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous